Kwick Forensic Solutions Limited

This section provides an overview of the industry context, including disclaimers regarding the sources of industry data and the inherent uncertainties in market projections. It discusses the slowdown in the global economy projected for 2025 and 2026, attributing this to inflation, geopolitical tensions, and monetary policies. Furthermore, it details the macroeconomic situation in India, noting its position as a fast-growing economy and the impact of government infrastructure spending. The analysis also covers sectoral contributions to Gross Value Added (GVA) in India, showing moderation in the industrial sector while the services sector remained the main driver of growth.

The provided text discusses various economic indicators, inflation trends, and the landscape of the crime scene investigation (CSI) in India. It details moderation in industrial sector performance across different indices, fluctuations in retail inflation, and the impact of Reserve Bank of India (RBI) monetary policy changes. Furthermore, the text delves into the evolving criminal landscape, noting the rise of complex crimes and the need for forensic services to address these challenges. It also compares conviction rates between Indian Penal Code (IPC) and Special & Local Laws (SLL) crimes, highlighting disparities in judicial efficiency.

The text discusses challenges in India's criminal investigation landscape, such as inefficiencies in evidence collection and inadequate training, which contribute to low conviction rates. In response, various modernization schemes have been introduced, including the National Forensic Infrastructure Enhancement Scheme (NFIES), which aims to strengthen the forensic and criminal investigation ecosystem through infrastructure upgrades and manpower expansion. Furthermore, significant legal reforms like the Bharatiya Nyaya Sanhita (BNS), Bharatiya Nagarik Suraksha Sanhita (BNSS), and Bharatiya Sakshya Adhiniyam (BSA) have been enacted to modernize the legal framework, introduce victim-centric approaches, and support scientific evidence handling. The digital landscape has also spurred investments and initiatives to combat cybercrime, including the establishment of specialized cyber forensic infrastructure and coordination centers.

The company, Kwick Forensic Solutions Limited, evolved from software development in 3D rendering to focus on forensic training and subsequently expanded into various forensic science and technology domains. The company received support and funding from the Ministry of Science & Technology, the Directorate of Forensic Science, and TIFAC for developing an Interactive Virtual Reality Crime Scene Simulator. The business has expanded into fingerprint science, cyber/digital forensics, social-media analytics, big-data analytics, and handheld field devices for evidence identification and digitization. The company provides end-to-end products and solutions for forensic sciences across India, serving government and private sector clients. Key product offerings include forensic kits, mobile CSI vehicles, digital tools, and DNA evidence management systems.

The company offers a range of forensic tools and scientific kits, which constitute approximately 30-40% of its total revenue. These offerings include various kits for evidence collection, as well as in-house developed handheld devices. The company procures some tools from global leaders and assembles them at its registered office. The products are designed for use by police departments and investigators in crime scene investigations and laboratory analysis.

The company offers a diverse portfolio of forensic products and services spanning several segments. This includes portable fuming chamber kits for fingerprint development, dry-safe evidence cabinets, and various digital forensic tools such as imaging devices, write blockers, and mobile triage kits. Furthermore, the company operates in the DNA forensics segment by supplying kits, genetic analyzers, and DNA database management software. The company also provides solutions for cyber and digital forensics, covering tools for extracting and analyzing electronic data.

The company provides various services related to forensic equipment, including leasing and sub-leasing of systems, and deploying other forensic equipment for detection, scanning, and X-ray imaging for clients. The services portfolio involves renting purchased products from Original Equipment Manufacturers (OEMs) and sub-leasing OEM products after leasing them first. The company deploys a team of 12 contract personnel at client locations to ensure 24-hour operational support. Key products include the MINI Z system, which is a comprehensive handheld imaging system capable of scanning various targets. The company follows a structured order execution flow involving tender search, execution, and after-sales services like AMC and training programs.

The company has received several industry recognitions, including awards from Thermo Fisher Scientific and various forensic science summits. The company maintains strong relationships with leading Original Equipment Manufacturers (OEMs) for product supply and has established robust quality assurance processes covering procurement to delivery. The business operates in a specialized segment serving government departments and law enforcement agencies, leveraging deep industry trust. Strategically, the company is scaling its forensic capabilities in line with government priorities, including developing in-house evidence collection equipment and creating software solutions to support the new legal framework for digital evidence collection.

The company procures forensic products and tools from OEMs through non-exclusive distributorship agreements or purchase orders, while also engaging in domestic sourcing to reduce import costs and improve gross margins. The company maintains a balanced procurement strategy, utilizing both domestic production and strategic imports to ensure quality and supply continuity. The company has developed a flexible logistics network to serve various clients across India, employing models for direct delivery from import customs houses and central dispatch from its office-cum-warehouse. The company has established power and water access at its registered and branch offices in Chennai, though it lacks power backup arrangements. Furthermore, the company offers structured warranty and post-sales support for its products, differentiating services based on whether the product is in-house assembled or OEM equipment.

The company's activities involve identifying departmental requirements to determine the appropriate products and services offered, and the sales team actively informs departments about technological advancements and innovations in forensic products. The company has not entered into any technical or other collaborations to date. Regarding obligations, the company currently has no export obligations. Capacity and utilization are not applicable as the business is not in the manufacturing sector with specified installed capacity. Performance guarantees for orders are provided through bank guarantees to customers, which are disclosed as contingent liabilities. Furthermore, the company is not a manufacturing unit and does not own major plant and machinery, relying instead on office equipment for operations.

This section provides various financial ratios, operational performance indicators, and details regarding the company's intellectual property and physical assets. It outlines key performance indicators such as Debt to Equity Ratio, Return on Assets, and various revenue and profit margins. Furthermore, it details the registration status of trademarks and domain names, lists insurance policies, and describes the company's operational properties, including a registered office and a branch office used for R&D and a private forensic laboratory proof-of-concept.

The company's operations are subject to various central and state legislations, including taxation statutes like the I.T. Act, GST, and Labour laws. The text details several key laws and regulations pertinent to the business, such as guidelines for Research and Development (R&D) centers, standards for forensic science laboratories, and various acts governing weights and measures, information technology, and employment conditions. Furthermore, the company must comply with laws related to the establishment of shops and other trade regulations, as well as various provisions under the Code on Wages and the Occupational Safety, Health and Working Conditions Code.

This section primarily discusses various Indian laws and regulations pertaining to labour, intellectual property, foreign investment, data protection, and general laws that apply to the company. It details provisions within the Industrial Relations Code concerning fixed-term employment, strikes, and lay-off procedures. It also covers the consolidation of laws related to social security, the framework for trade regulation, rules for foreign investment, and various regulations concerning the processing and protection of digital personal data. Furthermore, the text lists numerous general laws that are applicable to the company's operations.

The company, originally incorporated as Kwick Soft Solutions Private Limited, underwent several name changes and a conversion from a Private to a Public Limited company over a period spanning from 2005 to 2025. Key name changes occurred in 2024 and 2025, culminating in the name change to Kwick Forensic Solutions Limited upon conversion to a public entity. The company's registered office has had multiple shifts since its incorporation. Furthermore, the company has faced regulatory actions, including filing for object clause alterations and penalties related to certain activities.

The company has disclosed that it has not entered into agreements with key managerial personnel, senior management, directors, promoters, or employees concerning compensation or profit sharing with shareholders or third parties as of the prospectus date. Furthermore, the company is not party to any collaboration agreements and does not have any strategic or financial partners. The company has not acquired any material business or undertaken mergers or amalgamations in the last ten years, nor has it divested any business/undertaking in the same period. The company has 42 shareholders as of the prospectus date, and details regarding the shareholding pattern can be found in a separate chapter. Finally, certain guarantees related to loans sanctioned by the promoter as of March 31, 2026, are mentioned.

This section defines various terms and abbreviations used within the Prospectus. It specifies that the company is Kwick Forensic Solutions Limited, incorporated under the Companies Act, 1956, with a Corporate Identification Number U72200TN2005PLC055566, and its registered office is located in Chennai, Tamil Nadu. The definitions also detail various legal, financial, and procedural terms related to the issue, including different types of investors, offer components, and timelines.

The document outlines various agreements and definitions related to an offer process, including the roles of the Lead Manager and Market Makers. The Market Maker is specified as R. K. Stockholding Pvt. Ltd, which has agreed to receive or deliver securities for a period of three years from the listing date. The offer involves a specific number of Equity Shares, and details are provided regarding the net issue amount. The document also defines various investor types, such as Non-Institutional Applicants and Qualified Institutional Buyers (QIBs), and details related to payment methods and regulatory frameworks.

This section details various conventions, definitions, and references used within the Prospectus, covering aspects like the use of various acronyms, definitions of terms across different chapters, and conventions for financial data and currency presentation. It specifies that certain defined terms are detailed in sections concerning the Articles of Association, business operations, risk factors, and financial discussions. Furthermore, it establishes conventions for industry data sourcing and includes important disclaimers regarding forward-looking statements and inherent risks.

This section details the capital structure of the company, including the authorized, issued, and paid-up share capital, as well as various aspects of the offer process. It outlines the structure of the offer, including different portions like the Market Maker and Net Offer to the Public, and the subsequent changes to the share capital after the offer. Furthermore, it provides historical details on the allotment and issuance of equity shares, including various allotments through different means like cash subscription, rights issues, private placements, and bonus issues.

The section details the shareholding pattern of the company as per Regulation 31 of the SEBI (LODR) Regulations, 2015, as of the prospectus date. It provides a breakdown of shareholding across different categories, including Promoters and Promoter Group, as well as various shareholding percentages. Furthermore, the section lists major shareholders holding 1.00% or more of the paid-up capital, both as of the prospectus date and ten days prior. It also shows the build-up of promoter shareholding through various transactions, including allotments and transfers.

This section details various transactions involving the transfer of shares, including gifts from several individuals, which occurred on different dates. It also outlines the issuance of bonus shares and right issues, along with the subsequent allotment of shares to certain parties. Furthermore, the section discusses promoter contributions, including a minimum requirement, and various lock-in periods for equity shares held by promoters and others. It also clarifies rules regarding the pledge of locked-in equity shares and the transferability of such shares.

This section details various compliance and procedural aspects related to the public offer, including policies regarding employee stock schemes, the handling of oversubscription, and the status of securities. It clarifies that no outstanding warrants or options exist as of the prospectus filing date, and that all equity shares are fully paid up. Furthermore, it outlines restrictions on certain participants and mandates for reporting transactions between the company and its promoter group.

The Offer involved a combination of a Fresh Offer and an Offer for Sale, aggregating to a total of ₹ 5077.44 Lakhs from the Fresh Offer and ₹ 972.00 Lakhs from the Offer for Sale. The Offer for Sale proceeds were subject to deductions for offer-related expenses and taxes, with the company not receiving any proceeds from this part. The Net Proceeds from the Fresh Issue were estimated at ₹ 3606.85 Lakhs after deducting offer-related expenses. The proposed utilization of these net proceeds was planned for funding working capital requirements and general corporate purposes.

This section details various aspects of the company's working capital requirements, including the relationship between current assets and liabilities relative to revenue. It discusses the growth in working capital needs driven by increases in trade receivables, inventories, and other current assets, which reflect an expanding scale of operations and extended credit terms in the industry. Furthermore, it outlines trends in trade receivables, trade payables, and other current liabilities over several fiscal years, showing shifts towards improved credit control and faster payment cycles. The text justifies the need for higher working capital funding to support operational cycles and ensure business continuity.

The section details the movement of working capital over fiscal years, showing increases and decreases in various components like current assets, liabilities, and provisions. It also outlines the proposed deployment of funds for general corporate purposes, specifying limits on the amount that can be used for business development and marketing. Furthermore, the text discusses various offer-related expenses, including fees and commissions, and clarifies that these expenses are shared between the company and the selling shareholder. It also includes provisions regarding the use of net proceeds, the possibility of bridge financing, and restrictions on investing in other listed companies or real estate.

The basis for determining the offer price involves consultation with the BRLM based on the Book Building Process and various quantitative and qualitative factors. The issue floor price is set at ₹85, which is 8.5 times the face value of the equity shares, and the issue cap price is set at ₹90, which is 9 times the face value. Several qualitative factors, such as the experienced promoter team and diversified revenue streams, are considered in the pricing. Quantitative factors include various Earnings Per Share (EPS) figures, Price/Earning ratios, Return on Net Worth, and Net Asset Value per share, all derived from restated financial statements. The company confirms its commitment to disclose Key Performance Indicators (KPIs) periodically.

The provided text discusses various aspects related to the issuance of equity shares and the associated tax benefits for the company and its shareholders. It details information regarding the issuance of bonus shares over an 18-month period, the absence of certain secondary sales transactions, and justifications for the issue price. Furthermore, it includes a statement concerning special tax benefits under the Income Tax Act and GST laws, clarifying the company's option for a specific tax rate and the status of benefits for shareholders.

This section primarily deals with the limitations and disclaimers regarding the applicability of certain direct and indirect tax laws. It clarifies that the statement only covers specific benefits under those laws and does not encompass benefits under any other legislation. Furthermore, the document explicitly states that there is no guarantee that revenue authorities or courts will agree with the expressed views, as the views are based on the existing interpretation of the law, which is subject to change. The company also disclaims responsibility for updating these views following any such changes.

Investors should be aware that the company's products and services are heavily concentrated in specific states, namely Bihar and Gujarat, making the business vulnerable to adverse developments in these regions. The company also lacks long-term agreements with most customers, which exposes it to risks from customer cancellations or changes to orders. Furthermore, the revenue structure is heavily dependent on the Sales of Goods and Sales of Services segments, meaning any decline in demand for these areas could negatively impact the business. Finally, there are documented instances of delays in filing various statutory returns, which carry the risk of regulatory penalties.

The company faces risks related to supply chain dependencies, including reliance on a limited number of suppliers for raw materials, which could negatively impact operations. There are also past instances involving non-compliance with the Memorandum of Association regarding forensic product activities, which led to corrective actions. Furthermore, the company sources products from international markets, exposing it to risks from changes in government regulations, import duties, currency fluctuations, and geopolitical tensions. The business is also highly dependent on government entities for revenue, making it vulnerable to changes in government policies or payment delays. Finally, the business is working capital intensive, and there is uncertainty regarding the renewal of rental agreements for the company's office and laboratory premises.

The risk factors outlined in this section cover several areas, including dependence on external factors for raw material procurement, contingent liabilities related to bank guarantees, and potential issues with regulatory compliance and litigation. The company faces risks from price volatility affecting raw material costs, the potential for adverse impacts from outstanding litigation, and delays in statutory filings like EPF and ESIC remittances. Furthermore, the company's trademarks are not yet registered, posing a risk to its intellectual property protection.

The company faces several risks related to intellectual property, including pending trademark applications and the lack of legal ownership over registered trademarks. There are concerns regarding past non-compliances with the Companies Act, 2013, and delays in filing statutory forms. Furthermore, the company relies on third-party transporters for raw material sourcing and product delivery, which exposes them to supply chain disruptions. The business also depends on OEM partners, and any changes in their policies or product updates could impact service offerings. Finally, there is a risk related to employee attrition and the inability to secure necessary regulatory approvals in a timely manner.

The prospectus highlights several risks related to execution delays, related party transactions, and reliance on key personnel. Risks include potential cost escalations due to order delays, the lack of proceeds from an Offer for Sale, and potential conflicts arising from related party dealings. Furthermore, the company faces risks concerning the adequacy of insurance coverage for various assets and the potential for changes in Indian regulations. The success of the business is heavily dependent on the expertise and retention of directors, promoters, and key managerial personnel. There are also concerns about the volatility of the equity share price and the difficulty in managing inventory levels.

The prospectus outlines numerous risks that could materially affect the company's equity shares and operations. Risks include market fluctuations, potential issues with the listing process, reliance on external economic and political factors, and exposure to various regulatory and natural events. Specific concerns involve the volatility of the market, changes in government regulations, currency fluctuations, infrastructure issues, and the impact of political instability or natural calamities on business operations and financial performance.

The section outlines the criteria for classifying various legal and regulatory proceedings as 'material' based on thresholds related to company turnover, net worth, and profit or loss. It specifies that civil litigations are considered material if the aggregate amount exceeds ₹41.50 Lakhs, if a single litigation's decision might affect others, or if the liability is not quantifiable but could adversely affect the business. Furthermore, the section details materiality policies for outstanding dues to creditors and confirms the absence of certain types of pending litigation against the company, promoters, directors, and key managerial personnel as of the prospectus date.

The company has obtained various necessary consents, licenses, permissions, registrations, and approvals from Central and State Governments and other regulatory authorities to conduct its business activities, with the understanding that these approvals do not guarantee the financial soundness of the company or the accuracy of its statements. Several approvals were obtained in connection with the Issue, including board resolutions and authorizations from selling shareholders. The company has also entered into agreements for the dematerialization of its shares with the Central Depository Services (India) Limited and the National Securities Depository Limited Ekpai. Furthermore, the prospectus has detailed numerous authorizations related to tax, business certifications, and quality certifications.

The provided section details various regulatory approvals, trademark registrations, and confirmations regarding the offer for sale of equity shares. It lists several approvals obtained, including those related to Intellectual Property rights, and confirms that the company and its promoters have not been prohibited from accessing capital markets by regulatory authorities. Furthermore, it confirms compliance with the Companies (Significant Beneficial Ownership) Rules, 2018, and eligibility criteria for the offer, such as not being debarred from accessing the capital market or being a willful defaulter.

This section primarily details compliance with various regulations and requirements related to the filing and listing process, including SEBI (ICDR) Regulations. It outlines agreements with depositories for securities dematerialization, confirms the paid-up status of equity share capital, and specifies requirements for the Book Running Lead Manager regarding the filing and display of the prospectus. Furthermore, it covers aspects of underwriting, market making commitments, and conditions related to the number of allottees and potential liability for application money repayment.

This section primarily details compliance with various regulations related to the receipt and handling of promoter contributions for the issue, ensuring these funds are managed in escrow accounts and released according to specific conditions. It also covers certifications regarding the alignment of proposed activities with the company's Memorandum of Association and the issuance of dematerialized shares in compliance with the Companies Act and Depositaries Act. Furthermore, the text includes attestations about the disclosure adequacy, the process of due diligence, and the proper execution of agreements related to the transaction. Finally, it outlines procedures for filing the Draft Red Herring Prospectus with the Registrar of Companies and the process for obtaining permission from BSE to list the securities on its SME platform.

The provided section primarily details various legal and procedural aspects related to the company's offering, including liability under Section 447 of the Companies Act, 2013, and the consents obtained from various parties. It also clarifies the status of the company as an Unlisted Issuer and provides details regarding previous issues, commission/brokerage, and the mechanism for investor grievances. Furthermore, it outlines the process for resolving investor complaints and confirms that the company has not received any investor complaints in the preceding three years.

This section details the various legal and regulatory frameworks governing the offer of equity shares, including compliance with the Companies Act, SEBI regulations, and various circulars. It outlines the process for investors, such as the Application Supported by Blocked Amount (ASBA) and the Unified Payments Interface (UPI) mechanism, for applying. Furthermore, it specifies the terms for the ranking of equity shares, the authority for the offer, the mode of dividend payment, and the procedures related to the allotment, trading, and the potential withdrawal of the offer.

This section primarily details various procedural timelines and conditions related to the submission and processing of bids and offers, including specific timings for electronic and physical applications, rules for bid revisions, and consequences for delays in unblocking funds. It also outlines requirements for minimum subscriptions, rules regarding the allocation of equity shares, and criteria for migration to the main board of the BSE. Furthermore, it lists various regulatory and track record parameters that prospective applicants must meet.

This section details various aspects related to the offer, including restrictions on share transfers, rules for different investor categories, and procedures for allotment. It specifies that certain investors like Eligible NRIs, FPIs, and VCFs are treated equally, and outlines conditions for share transfers between residents and non-residents. Furthermore, it discusses the rules for allotment, including the use of dematerialized form, various reservation portions for different investor types, and specific criteria for bid sizes and lot sizes.

This section details various regulatory requirements and procedures related to public issues, including rules regarding the use of UPI for applications, the blocking of funds in bank accounts, and the allocation structure for different investor categories. It outlines specific rules for individual investors, non-institutional bidders, and the allocation of the Qualified Institutional Buyer (QIB) portion, including reservations for domestic mutual funds and life insurance companies. Furthermore, it specifies the process for bid acceptance, the timelines for allotment, and provisions for compensation in case of delays in fund unblocking.

This section details various procedural and regulatory aspects related to the allotment of Equity Shares, focusing heavily on the implementation of the Unified Payments Interface (UPI) mechanism. It outlines phased implementation of UPI, requirements for investor documentation, and procedures for handling investor grievances and fund blocking. Specific rules are provided regarding who can bid, the use of ASBA versus UPI, and the roles of various intermediaries in the application process.

This section details various eligibility criteria for investors in the offer, including different categories such as HUFs, Mutual Funds, FPIs, LLPs, Trusts, and various insurance and pension funds. It also outlines restrictions on who can make applications, such as minors, partnership firms, foreign nationals, and overseas corporate bodies, with specific provisions regarding Overseas Corporate Bodies (OCBs) and RBI regulations. Furthermore, the text specifies rules for the application size, including minimum lot sizes and revision procedures for applications, and details the process for bidding, including the duration of the bid/offer period, the handling of bids, and the mechanism for blocking and releasing funds.

This section details various procedural and eligibility requirements for investors and bidders in the offer process. It outlines rules regarding the form of allotment (dematerialized), trading on the stock exchange, and limits on the number of shares per application. It also specifies requirements for information disclosure, the submission of application forms, and rules concerning the identification numbers of bidders. Furthermore, it lays out specific terms for participation by Anchor Investors, including minimum bid amounts, allocation limits based on the size of the portion, and conditions for bid finalization.

This section details various restrictions and guidelines concerning who is permitted to bid in the issue, including different categories of investors such as NRIs, FPIs, VCFs, AIFs, Mutual Funds, HUFs, and NBFCs. It outlines specific rules regarding holding limits, documentation requirements, and how multiple bids from certain entities are treated. Furthermore, it specifies rules for bids made by different investor types, such as the requirement for specific forms or documentation depending on the investor category.

This section details various requirements and limitations concerning bids and applications from different entities participating in the offer, including insurance companies, various financial institutions, and Self Certified Syndicate Banks (SCSBs). It outlines specific documentation required depending on the bidder type, such as registration certificates, corporate documents, or proof of corpus for funds. Furthermore, it specifies rules regarding investment exposure limits for different sectors and outlines procedures for allotment, including the use of a Confirmation Note (CAN) and the Application Supported by Blocked Account (ASBA) process.

This section details various procedural and regulatory requirements for investors participating in the public issue, primarily focusing on the Application Supported by Blocked Amount (ASBA) process. It outlines arrangements with bankers and the Registrar, the use of different payment mechanisms like UPI, and the responsibilities of Designated Intermediaries in registering and handling applications. Furthermore, it specifies rules regarding the withdrawal of bids, the finalization of the offer price based on demand, and the registration process for the Red Herring Prospectus with the Registrar of Companies (ROC).

This section primarily outlines various instructions and prohibitions for bidders during the bidding process, focusing heavily on compliance with documentation, payment procedures, and technical requirements. It details numerous rules regarding the submission of forms, the use of different payment mechanisms like UPI, and the consequences for non-compliance, such as bid rejection. Furthermore, it specifies procedures for handling joint bids, multiple bids, and the flow of events from the bid closure until the final allotment, including validation by the Registrar and Transfer Agent (RTA) and the Designated Stock Exchange (DSE).

This section details various procedures related to the allotment of equity shares across different bidder categories, including Individual, Non-Institutional, and QIB bidders, based on the offer price and aggregate demand. It outlines specific rules for proportionate allotment, minimum share allocations, and procedures for handling oversubscription. Furthermore, the text covers aspects of investor instructions, the responsibility of various intermediaries, and undertakings by the company regarding the timely completion of formalities and refunds.

This section details various procedural requirements and undertakings related to the offer process, including timelines for communication, conditions for withdrawing an offer, and consequences for delays in allotment. It also outlines specific undertakings by the Promoters/Selling Shareholders concerning the shares offered, such as ensuring the shares are free of encumbrances and providing necessary cooperation. Furthermore, the text discusses restrictions on foreign investment in Indian securities, including provisions under FEMA and FDI policy, and conditions for investment by various categories of foreign investors (NRIs, OCI, FPIs). Finally, it clarifies the jurisdiction for the offering and sale of equity shares, stating they are conducted offshore and not registered under US securities laws.

This section details various provisions related to the Articles of Association of Kwick Forensic Solutions Limited, primarily concerning share capital, the issuance of various types of shares, and the company's lien rights over shares. It outlines rules for member entitlements, the process for issuing certificates, the handling of lost or damaged certificates, and the company's right to enforce a lien on shares for unpaid amounts. Furthermore, it covers the power of the Board to issue different securities, including preference shares and debentures, and the conditions under which such securities can be converted into equity shares.

This section primarily details the liability of joint holders for share calls, the effect of non-payment, the Board's power to waive interest, and various provisions concerning the transfer and transmission of shares. It outlines procedures for handling payments, the forfeiture of shares due to non-payment, and the rights of persons acquiring shares after the death or insolvency of a member.

This section of the DRHP outlines various provisions related to the Company's corporate actions, including the power to reduce share capital, definitions for terms like 'Beneficial Owner' and 'SEBI', and rules concerning the dematerialization of securities. It details procedures for transferring and holding securities, including provisions for electronic forms, joint holders, and liability concerning dividends and interest. Furthermore, the text covers the capitalization of profits, the buy-back of shares, and the procedures for calling general meetings, including requirements for notice and quorum.

This section primarily outlines procedural rules regarding the minutes of general meetings, the adjournment of meetings, voting rights, and the composition and powers of the Board of Directors. It details the Chairman's discretion in handling minutes, the process for inspecting minutes, rules for adjourning meetings, various voting methods, and stipulations concerning the appointment, tenure, and powers of the Board members. Furthermore, it covers the Board's authority to borrow money and the disclosure requirements for Directors' interests in contracts with the company.

This section primarily outlines procedural rules regarding meetings of the Board and committees, including how questions are decided, the role of the Chairman, and the delegation of powers to committees. It details provisions for the continuing tenure of directors and the requirements for quorum. Furthermore, the text covers the appointment and removal of key managerial personnel, the appointment of Managing Directors and Whole-Time Directors, and various provisions related to statutory registers, dividends, and the inspection of company accounts. It also covers indemnity provisions for directors and officers and the company's right to take insurance.

This section primarily details various material contracts and documents related to the offer, including agreements with promoters, lead managers, and various regulatory bodies. It lists numerous agreements dated around September and June 2025 and 2026, as well as various reports and resolutions concerning the offer and the company's financial status. The section also includes a declaration affirming compliance with relevant laws and the truthfulness of the statements made in the Prospectus.

The Board of Directors consists of five members, comprising two Executive Directors and three Non-Executive Directors, including two Non-Executive Independent Directors. The key personnel include the Chairman & Managing Director, Mr. Shammer Saralal Shah, who has extensive experience across various technology sectors. The Board also includes a Whole-time Director, Mr. Neeraj Bakulesh Jhaveri, who is responsible for marketing and business development. Furthermore, there are Non-Executive Directors, a Non-Executive Independent Director, and an Additional Director who brings significant medical expertise to the board.

The section details awards received by promoters, including several certificates for Mr. Ashok Hinduja, and a certificate for Mr. Shammer S Shah for completing a course on Artificial Intelligence. It also outlines family relationships between some of the directors and key managerial personnel. The text specifies terms and conditions for the employment of Executive Directors, including qualifications, previous employment, and remuneration details. Furthermore, it clarifies the interest of directors in the company's promotion and business, stating that directors do not have other interests in the company as of the prospectus date.

The company has established borrowing limits, which were approved by a special resolution, and there have been several changes in the Board of Directors within the last three years. The management organization structure details various directors and their functional areas. Corporate governance compliance includes adherence to SEBI Listing Regulations, and the company has constituted various committees such as the Audit Committee, Nomination and Remuneration Committee, and a CSR Committee. Details are provided regarding the composition and powers of these committees.

The company has constituted a Stakeholders’ Relationship Committee, which includes a Chairperson, an Additional Director, and a Whole-time Director, with the Company Secretary and Compliance Officer acting as the secretary. The committee's terms of reference cover various aspects such as share allotment, grievance redressal, and monitoring of share transfers. Key managerial personnel and senior management are permanent employees of the company, and there are no arrangements for bonus or profit-sharing plans. Furthermore, there are no contingent or deferred compensation arrangements for the key managerial personnel and senior management.

The management section details recent changes in key managerial personnel (KMP) and senior managerial personnel (SMP), including appointments and designation changes with effective dates spanning from April 1, 2023, to September 7, 2025. The section also clarifies that the company does not have any employee stock option scheme, nor has it granted any loans to directors, KMP, or SMP as of the prospectus date. Furthermore, it states that no benefits are provided upon the termination of employment except for statutory benefits or superannuation.